Rincon-Torroella Jordina, Rakovec Maureen, Khalafallah Adham M, Liu Ann, Bettegowda Anya, Kut Carmen, Rodriguez Fausto J, Weingart Jon, Luciano Mark, Olivi Alessandro, Jallo George I, Brem Henry, Mukherjee Debraj, Lim Michael, Bettegowda Chetan
1Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
2Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Neurosurg. 2022 Feb 11;137(4):931-942. doi: 10.3171/2021.12.JNS211643. Print 2022 Oct 1.
Subependymomas are low-grade ependymal tumors whose clinical characteristics, radiographic features, and postsurgical outcomes are incompletely characterized due to their rarity. The authors present an institutional case series and a systematic literature review to achieve a better understanding of subependymomas.
Adult patients with histologically confirmed subependymoma or mixed subependymoma-ependymoma surgically treated at a tertiary hospital between 1992 and 2020 were identified. A systematic literature review of the PubMed, Embase, Web of Science, and Google Scholar databases from inception until December 4, 2020, was conducted according to PRISMA guidelines. Data extracted from both groups included demographics, radiographic features, tumor characteristics, management, and follow-up variables.
Forty-eight unique patients with subependymoma were identified by chart review; of these patients, 8 (16.7%) had mixed subependymoma-ependymoma tumors. The median age at diagnosis was 49 years (IQR 19.8 years), and 26 patients (54.2%) were male. Forty-two patients (87.5%) had intracranial subependymomas, and 6 (12.5%) had spinal tumors. The most common presentation was headache (n = 20, 41.7%), although a significant number of tumors were diagnosed incidentally (n = 16, 33.3%). Among the 42 patients with intracranial tumors, 15 (35.7%) had hydrocephalus, and the most common surgical strategy was a suboccipital approach with or without C1 laminectomy (n = 26, 61.9%). Gross-total resection (GTR) was achieved in 33 cases (68.7%), and 2 patients underwent adjuvant radiotherapy. Most patients had no major postsurgical complications (n = 34, 70.8%), and only 1 (2.1%) had recurrence after GTR. Of 2036 reports initially identified in the systematic review, 39 were eligible for inclusion, comprising 477 patients. Of 462 patients for whom tumor location was reported, 406 (87.9%) were intracranial, with the lateral ventricle as the most common location (n = 214, 46.3%). Spinal subependymomas occurred in 53 patients (11.5%), with 3 cases (0.6%) in multiple locations. Similar to the case series at the authors' institution, headache was the most common presenting symptom (n = 231, 54.0%) among the 428 patients whose presentation was reported. Twenty-seven patients (6.3%) were diagnosed incidentally, and 36 cases (8.4%) were found at autopsy. Extent of resection was reported for 350 patients, and GTR was achieved in 250 (71.4%). Fifteen of 337 patients (4.5%) had recurrence or progression.
The authors' case series and literature review demonstrate that patients with subependymoma are well managed with resection and generally have a favorable prognosis.
室管膜下瘤是一种低级别的室管膜肿瘤,由于其罕见性,其临床特征、影像学特征和术后结果尚未完全明确。作者呈现了一个机构病例系列和系统的文献综述,以更好地了解室管膜下瘤。
确定1992年至2020年期间在一家三级医院接受手术治疗的组织学确诊为室管膜下瘤或混合性室管膜下瘤-室管膜瘤的成年患者。根据PRISMA指南,对PubMed、Embase、Web of Science和Google Scholar数据库从创建到2020年12月4日进行了系统的文献综述。从两组中提取的数据包括人口统计学、影像学特征、肿瘤特征、治疗方法和随访变量。
通过病历审查确定了48例独特的室管膜下瘤患者;其中8例(16.7%)为混合性室管膜下瘤-室管膜瘤。诊断时的中位年龄为49岁(四分位间距19.8岁),26例患者(54.2%)为男性。42例患者(87.5%)患有颅内室管膜下瘤,6例(12.5%)患有脊髓肿瘤。最常见的表现是头痛(n = 20,41.7%),尽管有相当数量的肿瘤是偶然诊断出来的(n = 16,33.3%)。在42例颅内肿瘤患者中,15例(35.7%)有脑积水,最常见的手术策略是枕下入路伴或不伴C1椎板切除术(n = 26,61.9%)。33例(68.7%)实现了全切除(GTR),2例患者接受了辅助放疗。大多数患者没有严重的术后并发症(n = 34,70.8%),只有1例(2.1%)在GTR后复发。在系统综述中最初确定的2036篇报告中,39篇符合纳入标准,包括477例患者。在报告肿瘤位置的462例患者中,406例(87.9%)为颅内肿瘤,最常见的位置是侧脑室(n = 214,46.3%)。脊髓室管膜下瘤发生在53例患者(11.5%)中,3例(0.6%)为多部位。与作者所在机构的病例系列相似,在报告了表现的428例患者中,头痛是最常见的表现症状(n = 231,54.0%)。27例患者(6.3%)是偶然诊断出来的,36例(8.4%)是在尸检时发现的。报告了350例患者的切除范围,250例(71.4%)实现了GTR。337例患者中有15例(4.5%)复发或进展。
作者的病例系列和文献综述表明,室管膜下瘤患者通过切除治疗效果良好,总体预后较好。